Tag pharma [76 articles] Export

Recent papers classified by the tag pharma.

	Pharmaceutical postmarket review: fact or fiction? [My Copy] Food and drug law journal, Vol. 62, No. 3. (2007), pp. 493-500. by Stephen J. Schanz posted to research pharma medicine by rickl on 2009-09-19 13:02:31 as
	Fact or fiction: the need for independent pharmaceutical policy research. [My Copy] Journal of general internal medicine, Vol. 24, No. 5. (May 2009), pp. 692-694. by Salomeh Keyhani, Alex Federman posted to research pharma medicine by rickl on 2009-09-19 12:59:27 as
	Target discovery from data mining approaches. [My Copy] Drug discovery today, Vol. 14, No. 3-4. (7 February 2009), pp. 147-154. by Yongliang Yang, S. James Adelstein, Amin I. Kassis posted to pharma mining by agomez on 2009-09-14 07:18:37 as along with 8 people and 1 group jfr eesruiz tonamswish mitko nicklynch sschurer guhjy zimbo1 ImagCom - Biomedical Text Computing
	Text-based knowledge discovery: search and mining of life-sciences documents [My Copy] Drug Discovery Today, Vol. 7, No. 11. (6 May 2002), pp. S89-S98. by R. Mack posted to pharma mining by agomez on 2009-09-14 07:17:32 as
	Homology modeling in drug discovery: current trends and applications [My Copy] Drug Discovery Today, Vol. 14, No. 13-14. (05 July 2009), pp. 676-683. by Claudio N. Cavasotto, Sharangdhar S. Phatak posted to structural pharma by agomez on 2009-09-14 07:15:22 as along with 2 people jerome sschurer
	Integrating Sequencing Technologies in Personal Genomics: Optimal Low Cost Reconstruction of Structural Variants [My Copy] PLoS Comput Biol, Vol. 5, No. 7. (10 July 2009), e1000432. by Jiang Du, Robert D. Bjornson, Zhengdong D. Zhang, Yong Kong, Michael Snyder, Mark B. Gerstein posted to sequencing pharma health genomics by operon on 2009-09-11 09:53:37 as along with 7 people tharris n00c nuin natstreet rdiaz dakelley guhjy
	The Material Culture of British Pharmaceutical Laboratories in the Golden Age of Drug Discovery (c. 193575) [My Copy] International Journal for the History of Engineering & Technology (July 2009), pp. 280-299. by Viviane Quirke posted to pharma history-science by Enro to the group STS on 2009-08-13 08:47:32 as
	Lilly's free web screening [My Copy] Nat Biotech, Vol. 27, No. 7. (July 2009), pp. 584-584. by Jim Kling posted to pharma by cdsouthan on 2009-08-08 09:17:23 as along with 1 person reyez
	Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. [My Copy] Current opinion in drug discovery & development, Vol. 12, No. 1. (January 2009), pp. 40-52. by E. Y. Xu, W. H. Schaefer, Q. Xu posted to metabolomic pharma by agomez on 2009-07-03 13:09:54 as
	SysBioMed report: advancing systems biology for medical applications. [My Copy] IET systems biology, Vol. 3, No. 3. (May 2009), pp. 131-136. by O. Wolkenhauer, D. Fell, P. De Meyts, et al.N. Blüthgen, H. Herzel, N. Le Novère, T. Höfer, K. Schürrle, I. van Leeuwen posted to pharma by agomez on 2009-07-03 13:09:32 as along with 2 people bertelsen reyez
	Can open-source R&D reinvigorate drug research? [My Copy] Nature Reviews Drug Discovery, Vol. 5, No. 9. (18 August 2006), pp. 723-729. by Bernard Munos posted to pharma by agomez on 2009-06-19 12:25:41 as along with 5 people and 3 groups klexa nicklynch joergkurtwegner noby dnugent Molecular-Modelling Drug-Design Cheminformatics
	Open-source science to enable drug discovery [My Copy] Drug Discovery Today, Vol. 13, No. 17-18. (September 2008), pp. 731-733. by A. Edwards posted to pharma by agomez on 2009-06-19 12:25:19 as along with 7 people pekrau guhjy nicklynch hpiwowar dullhunk zimbo1 psique
	The case for open-source software in drug discovery [My Copy] Drug Discovery Today, Vol. 10, No. 3. (01 February 2005), pp. 213-217. by W. Delano posted to pharma software by agomez on 2009-06-19 12:04:35 as along with 1 person rayhuang0924
	Buying into the knowledge game [My Copy] Nature, Vol. 428, No. 6984. (15 April 2004), pp. 775-775. posted to knowledge pharma by agomez on 2009-06-17 07:48:05 as
	Discovery informatics: its evolving role in drug discovery. [My Copy] Drug discovery today, Vol. 7, No. 18. (15 September 2002), pp. 957-966. by B. L. Claus, D. J. Underwood posted to pharma by agomez on 2009-06-17 07:47:14 as
	Computational knowledge integration in biopharmaceutical research. [My Copy] Briefings in bioinformatics, Vol. 4, No. 3. (September 2003), pp. 260-278. by D. Ficenec, M. Osborne, J. Pradines, et al.D. Richards, R. Felciano, R. J. Cho, R. O. Chen, T. Liefeld, J. Owen, A. Ruttenberg, C. Reich, J. Horvath, T. Clark posted to knowledge pharma by agomez on 2009-06-17 07:46:46 as
	Exploiting the potential of knowledge management in R&D and drug discovery: extracting value from information. [My Copy] Current opinion in drug discovery & development, Vol. 7, No. 3. (May 2004), pp. 314-317. by R. K. Scott posted to knowledge pharma by agomez on 2009-06-17 07:46:16 as along with 1 person nicklynch
	The promise of a virtual lab in drug discovery [My Copy] Drug Discovery Today, Vol. 11, No. 5-6. (March 2006), pp. 228-236. by Han Rauwerda, Marco Roos, Bob O. Hertzberger, Timo M. Breit posted to pharma by agomez on 2009-06-17 07:45:21 as along with 1 person alanrw
	Signal detection in the pharmaceutical industry: integrating clinical and computational approaches. [My Copy] Drug safety : an international journal of medical toxicology and drug experience, Vol. 30, No. 7. (2007), pp. 627-630. by M. Hauben posted to pharma by agomez on 2009-06-17 07:44:35 as
	Pathway analysis tools and toxicogenomics reference databases for risk assessment [My Copy] Pharmacogenomics, Vol. 9, No. 1. (January 2008), pp. 35-54. by Ganter, Brigitte, Zidek, et al. Nadine, Hewitt, R. Philip, Muller, Dieter, Vladimirova, Antoaneta posted to pathway pharma toxicogenomics by agomez on 2009-06-17 07:43:18 as along with 2 people mingzhi thegoose
	Virtual screening and its integration with modern drug design technologies. [My Copy] Current medicinal chemistry, Vol. 15, No. 1. (2008), pp. 37-46. by R. V. Guido, G. Oliva, A. D. Andricopulo posted to pharma screening by agomez on 2009-06-17 07:41:57 as
	Data mining in pharma sector: benefits. [My Copy] International journal of health care quality assurance, Vol. 22, No. 1. (2009), pp. 82-92. by J. Ranjan posted to pharma mining by agomez on 2009-06-17 07:37:27 as
	Distinct effects of delta9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. [My Copy] Archives of general psychiatry, Vol. 66, No. 1. (January 2009), pp. 95-105. by P. Fusar-Poli, J. A. Crippa, S. Bhattacharyya, et al.S. J. Borgwardt, P. Allen, R. Martin-Santos, M. Seal, S. A. Surguladze, C. O'Carrol, Z. Atakan, A. W. Zuardi, P. K. McGuire posted to cannabis emotion pharma by prerona on 2009-05-11 14:24:45 as
	Neural circuitry underlying pain modulation: expectation, hypnosis, placebo [My Copy] Trends in Cognitive Sciences, Vol. 7, No. 5. (May 2003), pp. 197-200. by A. Ploghaus posted to emotion pain pharma vas by ph on 2009-04-24 17:11:26 as
	Building a Pharmacological Lexicon: Small Molecule Discovery in Academia [My Copy] Mol Pharmacol, Vol. 72, No. 1. (1 July 2007), pp. 1-7. by John S. Lazo, Linda S. Brady, Ray Dingledine posted to lexicon pharma by Effie to the group NaCTeM on 2009-04-17 20:19:41 as along with 1 person kemo
	Designing active template molecules by combining computational de novo design and human chemist's expertise. [My Copy] Journal of medicinal chemistry, Vol. 50, No. 8. (19 April 2007), pp. 1925-1932. by E. W. Lameijer, R. A. Tromp, R. F. Spanjersberg, J. Brussee, A. P. Ijzerman posted to chemistry computational modelling molecular molecule pharma structure by operon on 2009-04-05 02:12:35 as
	Patients and the public deserve big changes in evaluation of drugs [My Copy] BMJ, Vol. 338, No. mar31_3. (31 March 2009), b1025. by Silvio Garattini, Iain Chalmers posted to pharma science society by Borelli on 2009-04-03 12:08:16 as
	Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion. [My Copy] Nuclear medicine communications, Vol. 29, No. 6. (June 2008), pp. 568-573. by H. Kanetaka, H. Hanyu, K. Hirao, et al.S. Shimizu, T. Sato, T. Akai, T. Iwamoto, K. Koizumi posted to discrimination pharma by ph on 2009-03-24 12:31:11 as along with 1 person monimonicas
	Chloride channels as drug targets [My Copy] Nature Reviews Drug Discovery, Vol. 8, No. 2. (19 January 2008), pp. 153-171. by Alan S. Verkman, Luis J. V. Galietta posted to cystic pharma by agomez on 2009-03-21 03:39:32 as
	Systems biology and combination therapy in the quest for clinical efficacy [My Copy] Nat Chem Biol, Vol. 2, No. 9. (September 2006), pp. 458-466. by Jonathan B. Fitzgerald, Birgit Schoeberl, Ulrik B. Nielsen, Peter K. Sorger posted to pharma by agomez on 2009-03-21 01:16:29 as along with 4 people and 2 groups mingzhi jaycopeland cdppublications xtizon SorgerLab CDP
	Finding multiple target optimal intervention in disease-related molecular network [My Copy] Mol Syst Biol, Vol. 4 (4 November 2008) by Kun Yang, Hongjun Bai, Qi Ouyang, Luhua Lai, Chao Tang posted to pharma by agomez on 2009-03-20 23:33:39 as along with 4 people sg45653 jbesnard sjung phoenixzxl
	A pharmaco-EEG study on antipsychotic drugs in healthy volunteers [My Copy] Psychopharmacology, Vol. 191, No. 4. (May 2007), pp. 995-1004. by Yoshimura, Masafumi, Koenig, et al. Thomas, Irisawa, Satoshi, Isotani, Toshiaki, Yamada, Keizo, Kikuchi, Mitsuru, Okugawa, Gaku, Yagyu, Takami, Kinoshita, Toshihiko, Strik, Werner, Dierks, Thomas posted to application drug eeg pharma by gkoenig on 2009-03-03 16:43:27 as
	Advertising of antihypertensive medicines and prescription sales in Australia [My Copy] Internal Medicine Journal, Vol. 9999, No. 999A. (2009) by Agnes Vitry, Yi H. Lai posted to advertising hypertension pharma by timsenior on 2009-02-18 05:09:52 as
	A possible therapeutic target for Lou Gehrig's disease [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 16. (20 April 2004), pp. 5701-5702. by Soumya S. Ray, Peter T. Lansbury posted to als pharma structure target therapeutic by zfekete to the group HEIRS ALS on 2008-12-08 14:28:50 as
	Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS [My Copy] Progress in Neurobiology, Vol. 85, No. 1. (May 2008), pp. 94-134. by B. Turner, K. Talbot posted to als pharma sod1 transgenic by zfekete on 2008-12-05 15:52:26 as
	Therapy development for ALS: Lessons learned and path forward [My Copy] Amyotrophic Lateral Sclerosis, Vol. 9, No. 3. (2008), pp. 131-140. by Veena Lanka, Merit Cudkowicz posted to als pharma phase-3 by zfekete on 2008-12-05 15:26:05 as
	Learning from failed trials in ALS [My Copy] The Lancet Neurology (05 November 2007) by M. Swash posted to als minocycline pharma phase-3 by zfekete on 2008-12-04 13:09:26 as
	Biopharmaceuticals: Biochemistry and Biotechnology [My Copy] (19 September 2003) by Gary Walsh posted to biology pharma textbook by ultrascichick on 2008-11-18 21:30:23 as
	A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context [My Copy] Health, Risk & Society, Vol. 4, No. 3. (2002), pp. 305-324. by John Abraham posted to medicine pharma policy risk-benefit sociology by ultrascichick on 2008-11-18 02:26:37 as along with 1 person ricmilne
	Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry [My Copy] Sociology, Vol. 40, No. 2. (1 April 2006), pp. 297-314. by Joan Busfield posted to science-studies sociology pharma history-medicine by ultrascichick on 2008-11-18 01:22:30 as along with 1 person ricmilne
	Analgesia (Handbook of Experimental Pharmacology) [My Copy] (10 November 2006) posted to medicine textbook pharma by ultrascichick on 2008-11-17 16:43:25 as
	Global Pharmaceuticals : Ethics, Markets, Practices [My Copy] (15 May 2006) by Adriana Petryna posted to access ethnography pharma healthcare by magdaw on 2008-11-16 03:58:47 as along with 2 people and 1 group eraikhel qbert medanthro
	The 3D Structure of the Binding Pocket of the Human Oxytocin Receptor for Benzoxazine Antagonists, Determined by Molecular Docking, Scoring Functions and 3D-QSAR Methods [My Copy] Journal of Computer-Aided Molecular Design, Vol. 19, No. 5. (May 2005), pp. 341-356. by Balazs Jojart, Tamas Martinek, Arpad Marki posted to pharma vhts by zfekete on 2008-10-15 09:22:53 as
	Penetratin and derivatives acting as antifungal agents [My Copy] European Journal of Medicinal Chemistry (29 February 2008) by M. Masman, A. Rodriguez, M. Raimondi, et al.S. Zacchino, P. Luiten, C. Somlai, T. Kortvelyesi, B. Penke, R. Enriz posted to pharma by zfekete on 2008-10-15 09:16:27 as
	Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential. [My Copy] Br J Pharmacol (14 January 2008) by S M M. Lawrie, J Hall, A M M. McIntosh, D G G. Cunningham-Owens, E C C. Johnstone posted to and genetic mol neuroimaging pharma by prerona on 2008-09-04 15:55:42 as along with 1 person isami
	Funding pharmaceutical innovation through direct tax credits [My Copy] Health Economics, Policy and Law, Vol. 2, No. 03. (2007), pp. 267-284. by Kristina M. Lybecker, Robert A. Freeman posted to credits funding innovation pharma tax by cmmorel on 2008-07-23 13:39:22 as
	Book Review: Meaning, Medicine and the `Placebo Effect.' By Daniel Moerman; Social Lives of Medicines. By Susan Reynolds Whyte, Sjaak van der Geest, and Anita Hardon [My Copy] Culture, Medicine and Psychiatry, Vol. 28, No. 2., 245. by Peter J. Guarnaccia posted to anthropology culture get medanth medical pharma by rayoulike on 2008-06-28 18:57:14 as
	Pharmaceutical Virtue [My Copy] Culture, Medicine and Psychiatry, Vol. 30, No. 2. (June 2006), pp. 157-174. by Martin, Emily posted to get history medanth medical pharma politics by rayoulike on 2008-06-28 18:49:38 as
	Manufacturing Consensus [My Copy] Culture, Medicine and Psychiatry, Vol. V30, No. 2. (30 June 2006), pp. 135-156. by David Healy posted to citation get medanth medical pharma politics writing by rayoulike on 2008-06-28 18:42:06 as along with 3 people and 2 groups paultr pseudopharm jago Integrative Expertise for Global Health Convention on Knowledge Commons
	A maximum common substructure-based algorithm for searching and predicting drug-like compounds [My Copy] Bioinformatics, Vol. 24, No. 13. (1 July 2008), pp. i366-374. by Yiqun Cao, Tao Jiang, Thomas Girke posted to chem pharma prediction by girschick on 2008-06-27 14:18:00 as along with 2 people babakap reyez

Note: You may cite this page as: http://www.citeulike.org/tag/pharma

Result page: 1 2 Next

skepticism	12
als	6
chem	6
medical	5
medicine	5
gabaa	4
pdf	4
anthropology	3
drugs	3
get	3
knowledge	3
medanth	3
mining	3
structure	3
14-benzodiazepines	2
diplomarbeit	2
discrimination	2
docking	2
emotion	2
free_energy	2
hanson_czajkowski_08_structural	2
health	2
history-science	2
lexicon	2
neaz_cho_08_2d-qsar	2
phase-3	2
politics	2
rbc_bme08	2
receptor	2
research	2
science	2
sociology	2
target	2
textbook	2
therapeutic	2
access	1
adme	1
application	1
bias	1
biology	1
citation	1
cme	1
computational	1
cpg	1
credits	1
cyp	1
cystic	1
data	1
depression	1
developing_countries	1
drug-discovery	1
drug-drug	1
drug-target	1
drug_discovery	1
eeg	1
forresearch	1
funding	1
genetic	1
genomics	1
graphical_models	1
healthcare	1
history-medicine	1
hypertension	1
industry	1
innovation	1
ligand	1
marketing	1
metabolomic	1
minocycline	1
modelling	1
mol	1
molecular	1
molecule	1
neglected_diseases	1
neuroimaging	1
outreach	1
pain	1
physics	1
policy	1
poverty	1
prodrugs	1
protein_protein_interactions	1
protein_structure	1
psychiatry	1
psychotropics	1
quality	1
ray_lansbury_05_small-molecule-mediated	1
risk-benefit	1
science-studies	1
screening	1
sequencing	1
society	1
sod1	1
software	1
structural	1
tax	1
toxicogenomics	1
vhts	1
voucher	1
writing	1

Tag pharma [76 articles] Export

Related Tags